Precision Medicine for More Oxygen (P4O2)—Study Design and First Results of the Long COVID-19 Extension

Nadia Baalbaki, Jelle M. Blankestijn, Mahmoud I. Abdel-Aziz, Jan de Backer, Somayeh Bazdar, Inés Beekers, Rosanne J.H.C.G. Beijers, Joop P. van den Bergh, Lizan D. Bloemsma, Harm Jan Bogaard, Job J.M.H. van Bragt, Vera van den Brink, Jean Paul Charbonnier, Merel E.B. Cornelissen, Yennece Dagelet, Elin Haf Davies, Anne M. van der Does, George S. Downward, Cornelis M. van Drunen, Debbie GachJ. J.Miranda Geelhoed, Jorrit Glastra, Kornel Golebski, Irene H. Heijink, Judith C.S. Holtjer, Sebastiaan Holverda, Laura Houweling, John J.L. Jacobs, Renée Jonker, Renate Kos, Ramon C.J. Langen, Ivo van der Lee, Asabi Leliveld, Firdaus A.A. Mohamed Hoesein, Anne H. Neerincx, Lieke Noij, Johan Olsson, Marianne van de Pol, Simon D. Pouwels, Emiel Rolink, Michael Rutgers, Havva ?ahin, Daphne Schaminee, Annemie M.W.J. Schols, Lisanne Schuurman, Gitte Slingers, Olie Smeenk, Brigitte Sondermeijer, Paul J. Skipp, Marisca Tamarit, A.H. Maitland-Van Der Zee^*, P4O2 ConsortiumShow 32 moreShow less